Department of Microbiology and Immunology

The University at Buffalo is playing a key role in helping Western New York defeat the COVID-19 pandemic.

Researchers in the Department of Microbiology and Immunology have developed a new, statistically more powerful method that can more effectively detect key functional pathways in cancer using genomics data generated by next-generation sequencing technology.

A University at Buffalo partnership with private industry is achieving great impact in the field of prosthetic design.

At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.

Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.

Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.

Agents that enhance the immune response to foreign molecules, called adjuvants, will likely play a role in developing a successful COVID-19 vaccine, according to Terry D. Connell, PhD, professor of microbiology and immunology.